Susan M. Geyer
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments 35
- Acute Myeloid Leukemia Research 20
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 56
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 48
- Oncology top 1%
- Cancer Treatment and Pharmacology 19
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 13
-
- Protein Degradation and Inhibitors 20
-
- Lung Cancer Treatments and Mutations 17
Susan M. Geyer
168 papers receiving 6.9k citations
Peers
Comparison fields: 5 of 129
- Hematology 2.7k
- Genetics 2.4k
- Pathology and Forensic Medicine 2.0k
- Oncology 2.7k
- Immunology 1.3k
Countries citing papers authored by Susan M. Geyer
This map shows the geographic impact of Susan M. Geyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan M. Geyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan M. Geyer more than expected).
Fields of papers citing papers by Susan M. Geyer
This network shows the impact of papers produced by Susan M. Geyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan M. Geyer. The network helps show where Susan M. Geyer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Susan M. Geyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 18 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 7 | |
| 9 | 2014 | 8 | |
| 10 | 2012 | 24 | |
| 11 | 2007 | 26 | |
| 12 | 2007 | 12 | |
| 13 | 2006 | 32 | |
| 14 | 2006 | 15 | |
| 15 | 2005 | 103 | |
| 16 | 2004 | 27 | |
| 17 | 2004 | 81 | |
| 18 | 2003 | 36 | |
| 19 | 2003 | 97 | |
| 20 | 1980 | 1 |
About Susan M. Geyer
Susan M. Geyer is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 175 papers that have together received 7.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (56 papers), Lymphoma Diagnosis and Treatment (48 papers), Multiple Myeloma Research and Treatments (35 papers), Acute Myeloid Leukemia Research (20 papers), Protein Degradation and Inhibitors (20 papers), Cancer Treatment and Pharmacology (19 papers), Lung Cancer Treatments and Mutations (17 papers) and Immunodeficiency and Autoimmune Disorders (13 papers). The work is most often cited by research in Hematology (2.7k citations), Genetics (2.4k citations) and Pathology and Forensic Medicine (2.0k citations). Susan M. Geyer has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Thomas E. Witzig, Angela Dispenzieri, Morie A. Gertz, Rafaël Fonseca, Martha Q. Lacy, Neil E. Kay, Robert A. Kyle, S. Vincent Rajkumar, Tait D. Shanafelt and John A. Lust. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.